The Pluripotent Stem Cell Core (Core A) is located in the Paul P. Coverdell Center for Biomedical and Health Sciences, adjacent to the Palton lab and the Administrative Core (Core C) for the Program. The Core will have two Specific Aims: 1. Stem cell resources and technical support for the Program's Projects This involves culturing of pluripotent cells, their differentiation into lineages of the three embryonic germ layers and distribution to the three Projects that make up the Program. Cells will be subject to stringent quality control by the Core. The Core will provide analytical and technical support for the Projects, will coordinate purchasing of reagents for the Program and will act as a repository for reagents and materials generated by the Program. The Core will also generate key reagents and modified cell lines for general use. 2.
This aim will provide a similar range of services to that described in Aim 1 but these will be specifically directed towards assisting the Pilot Projects. Additional support will be available on a more limited basis to investigators in the Southeast region with meritorious projects that provide additional synergy to the Program. Over the last 5 years the Core has developed technologies and expertise that will be essential for the success ofthe Projects and Pilot Projects in the upcoming renewal period. In addition to providing continuity of Project support, the Core will continually evolve by introducing new technologies that will accelerate progress.
Pluripotent stem cells are at the forefront of a new revolution in biomedical research and serve important roles in drug screening, disease modeling and regenerative medicine. This Core is focused on providing support for important research on the basic understanding of pluripotent stem cells so that in the future, they can be more effectively and safely used in clinical applications.
|Tang, J; Li, Y; Lyon, K et al. (2014) Cancer driver-passenger distinction via sporadic human and dog cancer comparison: a proof-of-principle study with colorectal cancer. Oncogene 33:814-22|
|Sima, Jiao; Gilbert, David M (2014) Complex correlations: replication timing and mutational landscapes during cancer and genome evolution. Curr Opin Genet Dev 25:93-100|
|He, Yangqing; Peng, Jiangnan; Hamann, Mark T et al. (2014) An iridoid glucoside and the related aglycones from Cornus florida. J Nat Prod 77:2138-43|
|Pope, Benjamin D; Ryba, Tyrone; Dileep, Vishnu et al. (2014) Topologically associating domains are stable units of replication-timing regulation. Nature 515:402-5|
|Boccuto, Luigi; Aoki, Kazuhiro; Flanagan-Steet, Heather et al. (2014) A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum Mol Genet 23:418-33|
|Kellis, Manolis; Wold, Barbara; Snyder, Michael P et al. (2014) Reply to Brunet and Doolittle: Both selected effect and causal role elements can influence human biology and disease. Proc Natl Acad Sci U S A 111:E3366|
|Liu, Deli; Xiong, Huan; Ellis, Angela E et al. (2014) Molecular homology and difference between spontaneous canine mammary cancer and human breast cancer. Cancer Res 74:5045-56|
|Gasimli, Leyla; Hickey, Anne Marie; Yang, Bo et al. (2014) Changes in glycosaminoglycan structure on differentiation of human embryonic stem cells towards mesoderm and endoderm lineages. Biochim Biophys Acta 1840:1993-2003|
|Lu, Junjie; Li, Hu; Hu, Ming et al. (2014) The distribution of genomic variations in human iPSCs is related to replication-timing reorganization during reprogramming. Cell Rep 7:70-8|
|Yue, Feng; Cheng, Yong; Breschi, Alessandra et al. (2014) A comparative encyclopedia of DNA elements in the mouse genome. Nature 515:355-64|
Showing the most recent 10 out of 38 publications